Cost-Effective Evaluation and Management of Cranial Neuropathy
List Price: $99.99
Cranial neuropathy can be a symptom of a devastating, life-threatening condition or a benign disease with spontaneous full recovery in a majority of patients. While testing options are available, they can be costly and sometimes may be unnecessary. Cost-Effective Evaluation and Management of Cranial Neuropathy by Seilesh C. Babu, Neal M. Jackson, and an impressive team of multidisciplinary contributors reflect decades of experience. Combining evidence-based medicine from the literature with years of firsthand expertise, this reader-friendly book offers cost-effective methodology and in-depth insights for evaluating and managing cranial neuropathy.
The textbook provides a clear-cut approach and practical algorithm for cranial nerve evaluation and management of neuropathy. Contributions from neurotologists, neurosurgeons, rhinologists, ophthalmologists, head and neck cancer surgeons, laryngologists, and speech language pathologists ensure a well-rounded and comprehensive approach. The text begins with an introduction to cost-effective management in medicine, laying a foundation for the book’s primary focus. It concludes with cranial neuropathy radiology considerations and a helpful cost-effective summary with key points.
Unique algorithms provide clinicians with simple-to-follow, cost-effective methods for managing complex disorders that result in facial nerve weakness, hearing loss, and swallowing problems
Pathology-specific chapters cover a wide range of conditions including olfactory disorders, vision disorders, audiovestibular disorders, facial and trigeminal nerve disorders, and spinal accessory nerve disorders
Diagnosis and management of cranial nerve disorder symptoms such as vision loss, dysphagia, and dysphonia
This excellent resource is a must have for all clinicians who potentially encounter patients with cranial nerve weakness, including primary care and emergency medicine physicians, otolaryngologists, neurologists, and neurosurgeons.
This book includes complimentary access to a digital copy on https://medone.thieme.com.
Epidural Steroid Injection
Epidural steroid injections (ESIs) are a common method for back pain management and treating inflammation associated with low back related leg pain, or neck related arm pain. In both of these conditions, the spinal nerves become inflamed due to narrowing of the passages where the nerves travel as they pass down or out of the spine.
They have been used in the treatment of lumbar radicular pain syndromes since 1952. These injections have been performed blind, using an interlaminar loss of resistance technique with a 13-30% incidence of improper localization of the space
One hundred forty-one patients met the inclusion/exclusion criteria; 89 received Epidural Steroid Injection (ESI) and 52 were treated with medical management alone. Both cohorts showed improved EQ-5D scores at 3 months but were similar to one another: ESI (ΔEQ-5D = 0.06; p = 0.03) and medical-alone (ΔEQ-5D = 0.07; p = 0.03). No significant difference was seen between groups for total costs ($2,190 vs. $1,772; p = 0.18) or cost-utility ratios ($38,710/QALY vs. $27,313/QALY; p = 0.73). At both the 3-month and 6-month endpoints, absolute differences in cost-utility were driven by overall costs as opposed to QALY gains. Medical management alone was more cost-effective at both points owing to lower expenditures, however, these differences were not significant. No benefits were seen in either group on the EQ-5D or any of the patient-reported outcomes at the 6-month time point.
ESIs were not cost-effective at either the 3-month or 6-month follow-up period. At 3 months, ESIs provide similar improvements in QOL outcomes relative to medical management and at similar costs. At 6 months, neither ESIs nor conservative management provides significant improvements in QOL outcomes 2).